338 related articles for article (PubMed ID: 32692785)
1. Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
Yadikar H; Torres I; Aiello G; Kurup M; Yang Z; Lin F; Kobeissy F; Yost R; Wang KK
PLoS One; 2020; 15(7):e0224952. PubMed ID: 32692785
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
3. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
[TBL] [Abstract][Full Text] [Related]
4. Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors.
Bretteville A; Marcouiller F; Julien C; El Khoury NB; Petry FR; Poitras I; Mouginot D; Lévesque G; Hébert SS; Planel E
Sci Rep; 2012; 2():480. PubMed ID: 22761989
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.
Noble W; Planel E; Zehr C; Olm V; Meyerson J; Suleman F; Gaynor K; Wang L; LaFrancois J; Feinstein B; Burns M; Krishnamurthy P; Wen Y; Bhat R; Lewis J; Dickson D; Duff K
Proc Natl Acad Sci U S A; 2005 May; 102(19):6990-5. PubMed ID: 15867159
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.
Planel E; Yasutake K; Fujita SC; Ishiguro K
J Biol Chem; 2001 Sep; 276(36):34298-306. PubMed ID: 11441005
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation.
Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ
CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846
[TBL] [Abstract][Full Text] [Related]
8. LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro.
Fu ZQ; Yang Y; Song J; Jiang Q; Lin ZC; Wang Q; Zhu LQ; Wang JZ; Tian Q
J Alzheimers Dis; 2010; 21(4):1107-17. PubMed ID: 21504119
[TBL] [Abstract][Full Text] [Related]
9. Both secreted and the cellular levels of BDNF attenuated due to tau hyperphosphorylation in primary cultures of cortical neurons.
Atasoy İL; Dursun E; Gezen-Ak D; Metin-Armağan D; Öztürk M; Yılmazer S
J Chem Neuroanat; 2017 Mar; 80():19-26. PubMed ID: 27914953
[TBL] [Abstract][Full Text] [Related]
10. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
Wu X; Kosaraju J; Tam KY
Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
[TBL] [Abstract][Full Text] [Related]
11. Rho-kinase ROCK inhibitors reduce oligomeric tau protein.
Hamano T; Shirafuji N; Yen SH; Yoshida H; Kanaan NM; Hayashi K; Ikawa M; Yamamura O; Fujita Y; Kuriyama M; Nakamoto Y
Neurobiol Aging; 2020 May; 89():41-54. PubMed ID: 31982202
[TBL] [Abstract][Full Text] [Related]
12. Tau Phosphorylation and Aggregation in the Developing Human Brain.
Hefti MM; Kim S; Bell AJ; Betters RK; Fiock KL; Iida MA; Smalley ME; Farrell K; Fowkes ME; Crary JF
J Neuropathol Exp Neurol; 2019 Oct; 78(10):930-938. PubMed ID: 31504677
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization.
Shirafuji N; Hamano T; Yen SH; Kanaan NM; Yoshida H; Hayashi K; Ikawa M; Yamamura O; Kuriyama M; Nakamoto Y
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562600
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β.
Wang XL; Zeng J; Yang Y; Xiong Y; Zhang ZH; Qiu M; Yan X; Sun XY; Tuo QZ; Liu R; Wang JZ
J Alzheimers Dis; 2015; 43(1):153-65. PubMed ID: 25079798
[TBL] [Abstract][Full Text] [Related]
15. Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model.
Lim YW; Yoon SY; Choi JE; Kim SM; Lee HS; Choe H; Lee SC; Kim DH
Biochem Biophys Res Commun; 2010 Apr; 395(2):207-12. PubMed ID: 20362550
[TBL] [Abstract][Full Text] [Related]
16. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
[TBL] [Abstract][Full Text] [Related]
17. Formaldehyde induces hyperphosphorylation and polymerization of Tau protein both in vitro and in vivo.
Lu J; Miao J; Su T; Liu Y; He R
Biochim Biophys Acta; 2013 Aug; 1830(8):4102-16. PubMed ID: 23628704
[TBL] [Abstract][Full Text] [Related]
18. Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid-induced neurodegeneration model.
Chen Z; Chen B; Xu WF; Liu RF; Yang J; Yu CX
Int J Dev Neurosci; 2012 Oct; 30(6):411-9. PubMed ID: 22906543
[TBL] [Abstract][Full Text] [Related]
19. Okadaic acid-induced tau hyperphosphorylation and the downregulation of Pin1 expression in primary cortical neurons.
Metin-Armağan D; Gezen-Ak D; Dursun E; Atasoy İL; Karabay A; Yılmazer S; Öztürk M
J Chem Neuroanat; 2018 Oct; 92():41-47. PubMed ID: 29860071
[TBL] [Abstract][Full Text] [Related]
20. Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture.
Li X; Lu F; Tian Q; Yang Y; Wang Q; Wang JZ
J Neural Transm (Vienna); 2006 Jan; 113(1):93-102. PubMed ID: 15959856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]